Reuters  Feb 23  Comment 
Danish drugmaker Novo Nordisk expects to raise between 1.7 billion and 2.2 billion Danish crowns ($259-335 million) from a stock market listing for NNIT [IPO-NNIT.CO], its...
Benzinga  Feb 20  Comment 
Shares of Novo Nordisk A/S (NYSE: NVO) were trading higher by more than 4 percent Friday morning after the company announced positive results from a phase 2 FDA trial. Novo Nordisk announced that it "has successfully completed the phase 2 trial...
Benzinga  Feb 20  Comment 
CollabRx Inc (NASDAQ: CLRX) -36% - Announced 3.84 million share offering. Noodles & Co (NASDAQ: NDLS) -28% - Reported Q4 EPS, downgraded at multiple firms. TrueCar Inc (NASDAQ: TRUE) -6.6% - Released Q4 EPS, offered Q1, FY2015 sales...
FierceBiotech  Feb 20  Comment 
Novo Nordisk's new oral diabetes drug measured up to its injected counterpart in a midstage study, promising results the company heralds as a milestone in the field.
Benzinga  Feb 20  Comment 
IPG Photonics Corporation (NASDAQ: IPGP) shares climbed 4.26% to $92.00 in pre-market trading. IPG Photonics reported Q4 earnings of $1.04 per share on revenue of $207.4 million. Novo Nordisk A/S (NYSE: NVO) shares surged 3.61% to $46.80 in...
Reuters  Feb 17  Comment 
Spain's Caixabank bid for full control of Portugal's third-largest lender Banco BPI on Tuesday and confirmed plans to pursue an acquisition of state-rescued Novo Banco to...
Reuters  Feb 16  Comment 
The Bank of Portugal has trimmed down the list of potential bidders for Novo Banco - the successor to Banco Espirito Santo after a state rescue - saying that 15 out of 17...
FierceBiotech  Feb 10  Comment 
Merck and Novo Nordisk are the latest pharma recruits for the GPCR Consortium, a global nonprofit working to shed light on an underexplored corner of biology and share its discoveries with the public.
Reuters  Feb 9  Comment 
* IPO could value IT business at up to $760 mln (Adds chairman and CEO quotes, analysts, background)

You may also be interested in articles related to Novo Nordisk A/S (NVO):


Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki